Antimicrobial prescribing by Belgian dentists in ambulatory care, from 2010 to 2016.
Antibiotics
antimicrobial utilisation
consumption
dentistry
odontogenic infection
Journal
International dental journal
ISSN: 1875-595X
Titre abrégé: Int Dent J
Pays: England
ID NLM: 0374714
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
pubmed:
4
8
2019
medline:
23
11
2019
entrez:
4
8
2019
Statut:
ppublish
Résumé
To describe antimicrobial prescribing by Belgian dentists in ambulatory care, from 2010 until 2016. Reimbursement data from the Belgian National Institute for Health and Disability Insurance were analysed to evaluate antimicrobial prescribing (WHO ATC-codes J01/P01AB). Utilisation was expressed in defined daily doses (DDDs), and in DDDs and packages per 1000 inhabitants per day (DID and PID, respectively). Additionally, the number of DDD and packages per prescriber was calculated. In 2016, the dentistry-related prescribing rate of 'Antibacterials for systemic use' (J01) and 'Antiprotozoals' (P01AB) was 1.607 and 0.014 DID, respectively. From 2010 to 2016, the DID rate of J01 increased by 6.3%, while the PID rate declined by 6.7%. Amoxicillin and amoxicillin with an enzyme inhibitor were the most often prescribed products, followed by clindamycin, clarithromycin, doxycycline, azithromycin and metronidazole. The proportion of amoxicillin relative to amoxicillin with an enzyme inhibitor was low. The narrow-spectrum antibiotic penicillin V was almost never prescribed. Antibiotics typically classified as broad- or extended-spectrum were prescribed most often by Belgian dentists during the period 2000-2016. Although the DID rate of all 'Antibacterials for systemic use' (J01) increased over the years, the number of prescriptions per dentist decreased since 2013. The high prescription level of amoxicillin with an enzyme inhibitor is particularly worrying. It indicates that there is a need for comprehensive clinical practice guidelines for Belgian dentists.
Identifiants
pubmed: 31376156
doi: 10.1111/idj.12512
pmc: PMC9379087
doi:
Substances chimiques
Anti-Bacterial Agents
0
Anti-Infective Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
480-487Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2019 FDI World Dental Federation.
Références
J Craniomaxillofac Surg. 2015 Mar;43(2):285-9
pubmed: 25555896
J Craniomaxillofac Surg. 2017 Oct;45(10):1731-1735
pubmed: 28838838
Clin Infect Dis. 2010 Jan 1;50 Suppl 1:S16-23
pubmed: 20067388
Am J Med Sci. 2003 Jan;325(1):31-3
pubmed: 12544082
Br J Gen Pract. 2016 Sep;66(650):460-1
pubmed: 27563120
Br Dent J. 1997 Aug 23;183(4):135-7
pubmed: 9293130
Heart. 2016 Jul 1;102(13):992-4
pubmed: 27288022
Periodontol 2000. 2015 Feb;67(1):131-86
pubmed: 25494600
Int Endod J. 2009 Dec;42(12):1112-7
pubmed: 19912383
Oral Microbiol Immunol. 2002 Oct;17(5):285-9
pubmed: 12354209
J Antimicrob Chemother. 2000 Dec;46(6):1033-5
pubmed: 11102428
Nat Rev Microbiol. 2015 May;13(5):269-84
pubmed: 25853778
BMJ. 2017 Sep 7;358:j3942
pubmed: 28882816
J Antimicrob Chemother. 2007 Jun;59(6):1161-6
pubmed: 17446241
J Am Dent Assoc. 2008 Jan;139 Suppl:3S-24S
pubmed: 18167394
J Antimicrob Chemother. 2014 Dec;69(12):3445-6
pubmed: 25204344
Arch Intern Med. 1996 Jun 24;156(12):1327-32
pubmed: 8651842
Heart. 2017 Jun;103(12):937-944
pubmed: 28213367
Br J Oral Maxillofac Surg. 2010 Jan;48(1):37-9
pubmed: 19178989
J Craniomaxillofac Surg. 2008 Dec;36(8):462-7
pubmed: 18760616
J Oral Maxillofac Surg. 2017 Dec;75(12):2606.e1-2606.e11
pubmed: 28893540
Dent Clin North Am. 2002 Oct;46(4):623-33, vii
pubmed: 12436820
Lancet. 2016 Jan 9;387(10014):176-87
pubmed: 26603922
Br Dent J. 2006 Nov 25;201(10):635-41
pubmed: 17128233
J Antimicrob Chemother. 2014 Jul;69(7):1981-6
pubmed: 24623832
Antibiot Chemother (1971). 1978;25:233-52
pubmed: 352255
Br Dent J. 2005 Jul 9;199(1):23-6
pubmed: 16003416